百家乐怎么玩-澳门百家乐官网娱乐城网址_网上百家乐是不是真的_全讯网888 (中国)·官方网站

Greater Bay Biotechnology

 

Greater Bay Biotechnology focuses on developing innovative microneedles device for drug and cell delivery. Our cryomicroneedles (CMNs) is an innovative device which allows effective storage, transportation, and in situ delivery of living cells, biologics and drug. Applications include diabetes treatment, cell and dermatology therapy.

Greater Bay Biotechnology is founded by researchers from City University of Hong Kong and is supported by CityU HK Tech 300 Seed Fund and The Hong Kong Science and Technology Parks Corporation (HKSTP) IDEATION Programme. We received multiple accolades for our innovation.

We work in partnership with pharmaceutical companies to develop innovative, minimally invasive and safe drug and cell delivery solutions. This include delivering insulin using our CMNs as a minimally invasive treatment option for the 130 million diabetes patients in China. We also expand the application of microneedles technology in the delivery of other drug, cosmetic and cell formulations.

 

 

Team members

Mr Ng Chelon Colin* (Master, Dept. of Biomedical Sciences, CityU)
Dr Zheng Mengjia (Postdoc, Dept. of Biomedical Engineering, CityU)
Ms Zhang Yuyue (PhD, Dept. of Biomedical Engineering, CityU)
Ms Zhang Jitian (PhD, Dept. of Biomedical Sciences, CityU)

* Person-in-charge
(Info based on the team's application form)

Achievement(s)
  1. CityU HK Tech 300 Seed Fund (2021)
  2. The Hong Kong Science and Technology Parks Corporation (HKSTP) IDEATION Programme
  3. Second runner-up, Hong Kong Chapter of “Maker in China” SME Innovation and Entrepreneurship Global Contest 2021
  4. Silver Prize, The 7th China International College Students’ “Internet+” Innovation and Entrepreneurship Competition
  5. Second prize, The 4th "Beijing-Hong Kong Youth Innovation and Entrepreneur Cup" Entrepreneurship Competition
  6. Third Prize, 2022 Chengdu "Rongpiao Cup" High-level Talents Innovation and Entrepreneurship Competition (Shuangliu District and Guangdong-Hong Kong-Macao Greater Bay Area Competition)
  7. Third prize, 2021 “創匯香湘" Innovation and Entrepreneurship Competition
  8. Selected to be in the Ministry of Industry and Information Technology (MIIT) First "Light of Innovation" SME technological innovation outstanding achievement list  (the only selected enterprise in Hong Kong, Macao and Taiwan)
  9. Selected to be as The 4th Guangdong-Hong Kong-Macao Greater Bay Area Top 50 Innovative Biotechnology Enterprises

 


全讯网334466| 大发888娱乐城 真钱| 网上百家乐官网赢钱公式| 博九网百家乐现金网| 百家乐专业豪华版| 百家乐官网免费下| 百家乐官网有破解的吗| 瑞丰国际娱乐场| 环球棋牌评测网| 百家乐娱乐平台真钱游戏| 博狗备用网址| 六合彩现场开奖| 德州扑克在线玩| 大发888真人斗地主| 百家乐官网真人游戏赌场娱乐网规则| 菲律宾赌球| 杨筠松古法风水24| 百家乐官网线上真人游戏| 百家乐官网视频表演| 百家乐侧牌器| 百家乐博彩通网| 百家乐大小点桌子| 百家乐英皇娱乐场| 大三元百家乐的玩法技巧和规则| 至尊百家乐赌场娱乐网规则| 百家乐官网群shozo权威| 澳门百家乐官网怎么下载| 百家乐冯耕耘打法| 百家乐赌场公司| 极速百家乐真人视讯| 大发888娱乐城官方| 德州扑克保险| 金冠娱乐城开户| 玩百家乐官网游戏经验| 百家乐官网计划策略| 网上百家乐赌博犯法吗| 大丰收百家乐的玩法技巧和规则| 百家乐官网稳赢玩法| 凯斯百家乐官网的玩法技巧和规则 | 大发888官网网址| 棋牌下载|